Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticaria.

Michèle Myriam RauberJ PickertL HolianguChristian Möbs Wolfgang Pfützner

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)

We here show that besides addressing IgE-dependent immune mechanisms, omalizumab treatment of CSU patients has effects on distinct T-cell subsets, which correlate with clinical improvement.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
induced apoptosis
chronic kidney disease
peritoneal dialysis
immune response
dendritic cells
patient reported outcomes
peripheral blood